| |
|
|
|
Kezar Life Sciences Inc  
|
|
6.16 0.68 (0.12%) |
03-01 16:00 |
|
Open: |
5.64 |
Pre close: |
5.48 |
Target:
|
7.63
|
|
High: |
6.17 |
Low: |
5.6248 |
Resistance:
|
6.53
7.40
|
|
Volume: |
157,347 |
Market Cap: |
286M |
Support:
|
5.12
4.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.69
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
5.80 |
Signal(12,26,9): |
0.08  |
|
MA(100): |
5.61 |
Stochastic Oscillator |
%K(14,3):
|
22.42 |
|
MA(250): |
5.13 |
%D(3): |
19.37 |
|
Average Volume(K) |
3-Month: |
21247
|
52-Week |
High:
|
9.79 |
|
10-Days: |
12094 |
Low: |
2.18 |
|
RSI |
RSI(14):
|
56.54 |
Change(%): |
19.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.110 |
Return on Equity (ttm) |
-34.1 |
Shares Out. (M) |
46.40 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.2 |
Shares Float (M) |
31.60 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
31.66 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.59 |
|
Forward EPS |
-1.840 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1200 |
|
Book Value (p.s.) |
3.250 |
EBITDA (p.s.) |
-0.870 |
P/E |
-5.55 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.85 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.68 |
P/CF |
-8.20 |
|
|
|
|
|
|
